Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-004 - Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition

      Presenter: Alicia Isabell Tüns

      • Abstract

      Loading...

  • +

    EP16.04 - Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
    • +

      EP16.04-002 - Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC

      Presenter: Anne Petzold

      • Abstract

      Loading...

  • +

    P1.14 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
    • +

      P1.14-05 - TROP2 Expression and SN38 Antitumor Activity in Malignant Pleural Mesothelioma Cells

      Presenter: Luca Hegedüs

      • Abstract

      Loading...